Beximco Pharmaceuticals reports 17.8% revenue rise in Q1
Beximco Pharmaceuticals reports 17.8% revenue rise in Q1
Beximco Pharmaceuticals reports 17.8% revenue rise in Q1
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.